Monograph Details
|
|
Ob/Gyn
> Vaginal infections
|
|
TERAZOL 7 |
| Manufacturer |
|
Ortho-McNeil Pharmaceuticals, Inc. |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Azole antifungal. |
| Generic Name |
|
Terconazole 0.4%; vaginal crm. |
| Indications |
|
Vulvovaginal candidiasis. |
| Children |
|
Not recommended. |
| Adults |
|
1 applicatorful vaginally at bedtime for 7 consecutive nights. |
| Precautions |
|
Confirm diagnosis by KOH smears and/or cultures. If ineffective, reconfirm diagnosis before repeating therapy. Discontinue if fever, chills, irritation, or sensitization occurs. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Adverse Reactions |
|
Headache, fever, chills, itching, body pain. |
| How Supplied |
|
Crm—45g (w. applicator) |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
